Heart, aging, and hypertension

Current Opinion in Cardiology

Volumn 16, Issue 6, 2001, Pages 336-341

  Varagic, Jasmina ^a   Susic, Dinko ^a   Frohlich, Edward D ^a  

^a OCHSNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; CARDIOVASCULAR SYSTEM; CORONARY ARTERY BLOOD FLOW; DIASTOLE; HEART FUNCTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE PERFORMANCE; HEART MUSCLE FIBROSIS; HUMAN; HYPERTENSION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECEPTOR BLOCKING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

AGING; CORONARY CIRCULATION; FIBROSIS; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MYOCARDIUM;

EID: 0035207734     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-200111000-00004     Document Type: Review

References (81)

1. Sex, age and disease affect echocardiographic left ventricular mass and systolic function in the free-living elderly. The cardiovascular Health Study
2. The heart in hypertension
3. Left ventricular hypertrophy: A pathophysiological and molecular biological perspective
4. Molecular mechanisms of myocardial remodeling
5. Cardiovascular regulatory mechanisms in advanced age
6. Myocyte cell loss and myocyte cellular hyperplasia in the hypertrophied ageing rat heart
7. Risk mechanisms in hypertensive heart disease
8. Cardiovascular aging in health
9. Senescent heart compared with pressure overload-induced hypertrophy
10. The influence of aging and aortic stiffness on permanent dilatation and braking stress of the thoracic descending aorta
11. Induction of the skeletal alpha-actin gene in alpha1-adrenoreceptor-mediated hypertrophy of rat cardiac myocytes
12. Angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibrosis in stroke-prone spontaneously hypertensive rats
13. A receptor blockade attenuates cardiac hypertrophy independently of blood pressure effects in renovascular hypertensive rats
14. Contribution of de novo protein synthesis to the hypertrophic effect of IGF-1 but not of thyroid hormones in adult ventricular cardiomyocytes
15. 2+-dependent transgenic model of cardiac hypertrophy: A role for protein kinase Calpha
16. The athlete's heart. A meta-analysis of cardiac structure and function
17. Coronary vasodilator capacity and epicardial vessel remodeling in physiological and hypertensive hypertrophy
18. Cardiac hypertrophy and coronary reserve in endurance athletes
19. Fibrosis and hypertensive heart disease
20. Pathologic fibrosis and connective tissue matrix in left ventricular hypertrophy due to chronic arterial hypertension in humans
21. Coronary hemodynamics in aging spontaneously hypertensive and normotensive Wistar-Kyoto rats
22. Impaired diastolic function and coronary reserve in genetic hypertension. Role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries
23. Prolonged L-arginine on cardiovascular mass and myocardial hemodynamics and collagen in aged spontaneously hypertensive and normal rats
24. Mechanical strain-induced extracellular matrix production by human vascular smooth muscle cells: Role of TGF-beta1
25. Role of mechanical factors in modulating cardiac fibroblast function and extracellular matrix synthesis
26. TGF-beta: Regulation of extracellular matrix
27. Collagen metabolism in cultured adult rat cardiac fibroblasts: Response to angiotensin II and aldosteron
28. Induction of cardiac fibrosis by aldosterone
29. Impact of aldosterone on left ventricular structure and function in young normotensive and mildly hypertensive subjects
30. Effect of norepinephrine on myocardial collagen gene expression and response of cardiac fibroblasts after norepinephrine treatment
31. Endothelin system-dependent cardiac remodeling in renovascular hypertension
32. Apoptosis, coronary remodeling, and myocardial infarction after nitric oxide inhibition in SHR
33. Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats
34. Angiotensin II activates collagen I gene through a mechanism involving the MAP/ER kinase pathway
35. Advanced hypertensive disease in spontaneously hypertensive rats. Lisinopril-mediated regression of myocardial fibrosis
36. Losartan inhibits the post-transcriptional synthesis of collagen type 1 and reverses left ventricular hypertrophy in spontaneously hypertensive rats
37. Differnetial effects of pressure or volume overload on myocardial MMP levels and inhibitory control
38. Abnormalities of the extracellular degradation of collagen type I in essential hypertension
39. Transforming growth factor beta in hypertensives with cardiorenal demage
40. Serum carboxyl-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease
41. Pharmacologic agents on cardiovascular mass, coronary dynamics and collagen in aged spontaneously hypertensive rats
42. Regression of myocardial fibrosis in hypertensive heart disease: Diverse effects of various antihypertensive drugs
43. Low-dose ACE with alpha- or beta-adrenergic receptor inhibitors have beneficial SHR cardiovascular effects
44. Biochemical components and myocardial performance after reversal of left ventricular hypertrophy in spontaneously hypertensive rats
45. Coronary hemodynamics and ventricular responses to AT1 receptor inhibition in SHR: Interaction with AT2 receptors
46. Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease
47. Repair of coronary arterioles after treatment with perindopril in hypertensive heart disease
48. Antifibrotic effects of N-acetyl-seryl-aspartyl-Lysyl-proline on the heart and kidney in aldosterone-salt hypertensive rats
49. Effect of N-acetyl-seryl-aspartyl-Lysyl-proline on DNA and collagen synthesis in rat cardiac fibroblasts
50. Reversal of cardiac hypertrophy and fibrosis by S21402, a dual inhibitor of neutral endopeptidase and angiotensin converting enzyme in SHRs
51. Effect of neutral endopeptidase inhibitor on endogenous atrial natriuretic peptide as a paracrine factor in cultured cardiac fibroblasts
52. Cardiac fibrosis in mice lacking brain natriuretic peptide
53. Age dependency of left ventricular diastolic function in pressure overload hypertrophy
54. Salt sensitivity, pulse pressure, and death in normal and hypertensive humans
55. Collagen phenotypes during development and regression of myocardial hypertrophy in spontaneoulsy hypertensive rats
56. Myocardial fibrosis in transforming growth factor beta (1) heterozygous mice
57. Nonsynchronous changes in myocardial mRNA and protein during aging. Effect of DOCA-salt hypertension
58. Differential regulation of matrix matalloproteinases associated with aging and hypertension in the rat heart
59. Diabetes: Breaking the curse of the AGEs
60. A cross-link breaker has sustained effects on arterial and ventricular properties in older rhesus monkeys
61. An advanced glycation endproduct cross-link breaker can reverse age-realted increases in myocardial stiffness
62. The relative protective effects of moderate dietary restriction versus dietary modification on spontantaneous cardiomyopathy in male Sprague-Dawley rats
63. Blood pressure, ventricular volume and number of cardiomyocyte nuclei in rats fed for 12 months on diets differing in fat composition
64. Collagen gene expression in rat left ventricle: Interactive effect of age and exercise training
65. Attenuated coronary flow reserve and vascular remodeling in patients with hypertension and left ventricular hypertrophy
66. Alterations of coronary blood flow and reserve with aging in Fischer 344 rats
67. Hypertension and left ventricular hypertrophy resistance are associated with impaired endothelium-mediated relaxation in human coronary vessels
68. Endothelium-derived contracting factor in carotid artery of hypertensive Dahl rats
69. Endothelium-mediated coronary blood flow modulation in humans: Effects of age, atherosclerosis, hypercholesterolemia, and hypertension
70. Ageing is associated with reduced basal and stimulated release of nitric oxide by the coronary endothelium
71. Increased endothelium-monocyte interactions in salt-sensitive hypertension: Effects of L-arginine
72. Enalapril and losartan reduced cardiac mass and improved coronary hemodynamics in SHR
73. Heart failure with normal systolic function
74. Roles of renin-angiotensin and endothelin systems in development of diastolic heart failure in hypertensive hearts
75. 2+ uptake
76. Long-term effects of amlodipine and lisinopril on left ventricular mass and distolic function in elderly, previously untreated hypertensive patients; The ELVERA trial
77. The effect of spironolactone on morbidity and mortality in patients with severe heart failure
78. Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure
79. A receptor antagonism
80. Synergistic effects of AT(1) and ET(A) receptor blockade in transgenic, angiotensin II-dependent, rat model
81. Autocrine-paracrine endothelin system in the physiology and pathology of steroid-secreting tissues